SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-037951
Filing Date
2024-03-22
Accepted
2024-03-22 17:19:20
Documents
6
Period of Report
2024-03-22

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm242879-1_pre14a.htm PRE 14A 812824
2 GRAPHIC lg_checkpointthera-4c.jpg GRAPHIC 70494
3 GRAPHIC sg_jamesfoliviero-bw.jpg GRAPHIC 4669
4 GRAPHIC sg_garrettgray-bw.jpg GRAPHIC 4613
5 GRAPHIC bc_paidvstsr-4c.jpg GRAPHIC 44435
6 GRAPHIC bc_paidvsnetloss-4c.jpg GRAPHIC 41808
  Complete submission text file 0001104659-24-037951.txt   1024601
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38128 | Film No.: 24776247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)